HomeSANA • NASDAQ
Sana Biotechnology Inc
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 48.77M | -53.71% |
Net income | -49.39M | 54.05% |
Net profit margin | — | — |
Earnings per share | -0.20 | 37.50% |
EBITDA | -45.12M | 55.59% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 104.70M | -66.34% |
Total assets | 445.47M | -34.62% |
Total liabilities | 236.39M | -22.81% |
Total equity | 209.08M | — |
Shares outstanding | 225.56M | — |
Price to book | 1.81 | — |
Return on assets | -25.76% | — |
Return on capital | -36.92% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -49.39M | 54.05% |
Cash from operations | -48.66M | 25.86% |
Cash from investing | 16.60M | 121.50% |
Cash from financing | 982.00K | -99.47% |
Net change in cash | -31.07M | -171.37% |
Free cash flow | -32.51M | 60.48% |
Previous close
$1.68
Day range
$1.63 - $2.04
Year range
$1.26 - $8.70
Market cap
449.01M USD
Avg Volume
3.25M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
2018
Headquarters
Website
Employees
194
